James T. LaFrance

Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.

LightIntegra Technology, Inc. develops medical device that analyzes the quality of platelets. It offers ThromboLUX, a medical device that characterizes platelet suspensions with a score reflecting the quantity of platelets, microparticles and other particles in the suspension. The company was founded in 2008 by Elisabeth Maurer-Spurej and is headquartered in Vancouver, Canada.

Omnyx LLC provides digital pathology workflow solutions. The firm delivers new digital pathology solutions for diagnostic medicine, and software and transformative consulting. The company is headquartered in Pittsburgh, PA.

MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL.

Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ.

Vermilion, Inc. is an international energy producer that focuses on acquiring, exploring, developing, and optimizing producing assets in various countries. Vermilion is based in Boulder, CO. The private company's business model emphasizes free cash flow generation and returning capital to investors when economically warranted, augmented by value-adding acquisitions. Vermilion's operations are focused on the exploitation of light oil and liquids-rich natural gas conventional resource plays in Canada and the exploration and development of conventional natural gas and oil opportunities in France and Australia. The company prioritizes health and safety, the environment, and profitability, in that order. The company was founded by Bob Morehouse, and Susan Touchette Aust has been the CEO of the company since 1992.